Market Cap ₹352 Cr.
Stock P/E 19.2
P/B 1.2
Current Price ₹271
Book Value ₹ 225
Face Value 10
52W High ₹407
Dividend Yield 0.37%
52W Low ₹ 191.7
Aries Agro Ltd is a renowned Indian company engaged in the manufacture and distribution of specialized plant nutrients and crop protection solutions. Established in 1969 and headquartered in Mumbai, Aries Agro has become a leading player in the agricultural sector. The company focuses on providing innovative and sustainable solutions to enhance crop productivity and optimize agricultural practices. Aries Agro offers a diverse range of products, including micronutrients, organic fertilizers, water-soluble fertilizers, and specialty agrochemicals. These products are designed to address specific nutritional requirements of various crops and improve soil health. With a strong emphasis on research and development, Aries Agro consistently strives to develop cutting-edge technologies and formulations to meet the evolving needs of farmers. Committed to promoting sustainable agriculture, Aries Agro emphasizes eco-friendly practices and encourages responsible usage of agrochemicals. The company's products are widely used across India and several international markets, contributing to higher yields and quality produce. Aries Agro's dedication to innovation, quality, and customer satisfaction has earned it a reputable position in the agriculture industry.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 138 | 133 | 93 | 107 | 158 | 147 | 107 | 135 | 194 | 170 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income | 138 | 133 | 93 | 107 | 158 | 147 | 107 | 135 | 194 | 170 |
| Total Expenditure | 113 | 118 | 93 | 95 | 129 | 130 | 108 | 120 | 159 | 149 |
| Operating Profit | 24 | 15 | -0 | 13 | 29 | 17 | -1 | 15 | 34 | 22 |
| Interest | 7 | 6 | 5 | 4 | 9 | 4 | 5 | 3 | 8 | 5 |
| Depreciation | 2 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 16 | 7 | -8 | 7 | 18 | 11 | -8 | 11 | 24 | 15 |
| Provision for Tax | 3 | 2 | 1 | 3 | 6 | 4 | -2 | 3 | 5 | 3 |
| Profit After Tax | 13 | 5 | -10 | 5 | 12 | 8 | -6 | 7 | 19 | 11 |
| Adjustments | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Profit After Adjustments | 14 | 5 | -9 | 5 | 12 | 8 | -6 | 7 | 19 | 12 |
| Adjusted Earnings Per Share | 11.1 | 3.9 | -7.2 | 3.7 | 9.6 | 6 | -4.3 | 5.6 | 14.5 | 8.9 |
| #(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 298 | 305 | 263 | 253 | 291 | 265 | 296 | 381 | 432 | 472 | 516 | 606 |
| Other Income | 2 | 1 | 1 | 3 | 2 | 3 | 7 | 0 | 4 | 9 | 3 | 0 |
| Total Income | 300 | 306 | 264 | 256 | 293 | 269 | 303 | 382 | 436 | 481 | 519 | 606 |
| Total Expenditure | 240 | 250 | 217 | 214 | 245 | 222 | 256 | 325 | 386 | 424 | 461 | 536 |
| Operating Profit | 59 | 56 | 47 | 42 | 48 | 47 | 47 | 57 | 51 | 57 | 58 | 70 |
| Interest | 25 | 24 | 25 | 23 | 29 | 29 | 26 | 26 | 24 | 23 | 22 | 21 |
| Depreciation | 9 | 10 | 11 | 7 | 2 | 2 | 5 | 6 | 6 | 8 | 8 | 8 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 25 | 22 | 12 | 12 | 17 | 16 | 16 | 25 | 20 | 25 | 28 | 42 |
| Provision for Tax | 7 | 3 | 4 | 7 | 8 | 8 | 7 | 7 | 7 | 9 | 10 | 9 |
| Profit After Tax | 18 | 19 | 8 | 5 | 9 | 8 | 9 | 17 | 13 | 16 | 18 | 31 |
| Adjustments | -3 | -2 | -1 | 2 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 1 |
| Profit After Adjustments | 16 | 17 | 7 | 7 | 9 | 8 | 11 | 18 | 13 | 16 | 18 | 32 |
| Adjusted Earnings Per Share | 12.2 | 13 | 5.6 | 5.4 | 7 | 5.9 | 8.1 | 13.8 | 10.2 | 12.2 | 14.1 | 24.7 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 9% | 11% | 14% | 6% |
| Operating Profit CAGR | 2% | 1% | 4% | -0% |
| PAT CAGR | 13% | 2% | 18% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 3% | 17% | 37% | 8% |
| ROE Average | 7% | 7% | 7% | 7% |
| ROCE Average | 15% | 14% | 14% | 13% |
| #(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 177 | 178 | 172 | 175 | 183 | 189 | 194 | 211 | 224 | 243 | 260 |
| Minority's Interest | 29 | 36 | 43 | 38 | 26 | 24 | 9 | 7 | 6 | 4 | 4 |
| Borrowings | 19 | 13 | 12 | 14 | 16 | 13 | 14 | 12 | 18 | 22 | 26 |
| Other Non-Current Liabilities | 7 | 5 | 6 | 6 | 6 | 6 | 11 | 12 | 10 | 13 | 14 |
| Total Current Liabilities | 216 | 211 | 216 | 217 | 246 | 262 | 258 | 259 | 251 | 238 | 213 |
| Total Liabilities | 448 | 444 | 448 | 450 | 477 | 494 | 487 | 501 | 509 | 520 | 517 |
| Fixed Assets | 100 | 87 | 87 | 71 | 88 | 95 | 48 | 55 | 68 | 75 | 96 |
| Other Non-Current Assets | 13 | 11 | 19 | 22 | 14 | 15 | 72 | 70 | 57 | 62 | 65 |
| Total Current Assets | 335 | 345 | 342 | 357 | 376 | 384 | 368 | 376 | 384 | 382 | 357 |
| Total Assets | 448 | 444 | 448 | 450 | 477 | 494 | 487 | 501 | 509 | 520 | 517 |
| #(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 21 | 13 | 5 | 4 | 6 | 6 | 4 | 1 | 1 | 1 | 2 |
| Cash Flow from Operating Activities | 31 | 38 | 34 | 48 | 14 | 44 | 59 | 56 | 69 | 55 | 77 |
| Cash Flow from Investing Activities | 2 | -11 | -25 | 13 | -2 | -10 | -41 | -14 | -13 | -16 | -26 |
| Cash Flow from Financing Activities | -41 | -31 | -9 | -59 | -12 | -36 | -21 | -43 | -56 | -37 | -50 |
| Net Cash Inflow / Outflow | -8 | -4 | -0 | 2 | 0 | -2 | -4 | -0 | 0 | 1 | 1 |
| Closing Cash & Cash Equivalent | 13 | 9 | 4 | 6 | 6 | 4 | 1 | 1 | 1 | 2 | 2 |
| # | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 12.24 | 12.97 | 5.56 | 5.43 | 6.99 | 5.92 | 8.14 | 13.81 | 10.22 | 12.25 | 14.15 |
| CEPS(Rs) | 20.87 | 22.35 | 14.42 | 9.33 | 8.73 | 7.78 | 10.77 | 18.16 | 14.4 | 18.28 | 20.1 |
| DPS(Rs) | 2 | 2 | 1.5 | 2 | 2.3 | 1.8 | 0.5 | 0.8 | 0.8 | 1 | 1 |
| Book NAV/Share(Rs) | 130.52 | 137.24 | 131.95 | 134.72 | 140.65 | 145.42 | 149.35 | 161.92 | 172.44 | 186.75 | 200.2 |
| Core EBITDA Margin(%) | 18.97 | 17.8 | 15.88 | 12.45 | 13.1 | 13.61 | 10.71 | 11.96 | 8.51 | 7.8 | 8.24 |
| EBIT Margin(%) | 16.73 | 15.05 | 12.72 | 11.29 | 13.02 | 13.89 | 11.21 | 10.66 | 8.17 | 7.97 | 7.53 |
| Pre Tax Margin(%) | 8.37 | 7.26 | 4.2 | 3.82 | 4.77 | 4.85 | 4.34 | 5.19 | 3.7 | 4.14 | 4.22 |
| PAT Margin (%) | 6.1 | 6.2 | 2.82 | 1.74 | 2.6 | 2.4 | 2.33 | 3.62 | 2.36 | 2.6 | 2.73 |
| Cash Profit Margin (%) | 8.97 | 9.38 | 6.47 | 3.88 | 3.24 | 3.16 | 3.77 | 4.98 | 3.42 | 3.88 | 3.88 |
| ROA(%) | 4.2 | 4.31 | 1.83 | 1.21 | 1.96 | 1.59 | 1.76 | 3.48 | 2.56 | 3.1 | 3.55 |
| ROE(%) | 11.47 | 11.03 | 4.67 | 3.14 | 5.08 | 4.14 | 4.51 | 8.48 | 5.95 | 6.82 | 7.31 |
| ROCE(%) | 14.68 | 13.46 | 10.79 | 10.85 | 13.69 | 12.45 | 11.81 | 14.67 | 13.26 | 14.59 | 15.15 |
| Receivable days | 140.27 | 155.03 | 157.25 | 152.06 | 169.18 | 209.71 | 148.44 | 92.06 | 80.43 | 70.56 | 62.79 |
| Inventory Days | 163.87 | 165.83 | 180.83 | 165.58 | 140.04 | 146.39 | 131.57 | 107.22 | 95.84 | 86.72 | 73.31 |
| Payable days | 120.33 | 124.42 | 114.65 | 116.89 | 132.52 | 209.93 | 193.67 | 119.6 | 108.98 | 108.14 | 85.28 |
| PER(x) | 4.66 | 8.15 | 16.2 | 28.49 | 25.22 | 14.65 | 4.91 | 5.6 | 13.37 | 12.08 | 17.11 |
| Price/Book(x) | 0.44 | 0.77 | 0.68 | 1.15 | 1.25 | 0.6 | 0.27 | 0.48 | 0.79 | 0.79 | 1.21 |
| Dividend Yield(%) | 3.5 | 1.89 | 1.66 | 1.29 | 1.3 | 2.07 | 1.25 | 1.03 | 0.59 | 0.68 | 0.41 |
| EV/Net Sales(x) | 0.8 | 0.97 | 1.04 | 1.3 | 1.34 | 1.04 | 0.67 | 0.61 | 0.65 | 0.6 | 0.73 |
| EV/Core EBITDA(x) | 4.04 | 5.22 | 5.79 | 7.8 | 8.14 | 5.88 | 4.21 | 4.05 | 5.55 | 5 | 6.49 |
| Net Sales Growth(%) | 18.26 | 2.35 | -13.79 | -3.9 | 15.36 | -8.92 | 11.62 | 28.81 | 13.34 | 9.22 | 9.36 |
| EBIT Growth(%) | 14.55 | -7.87 | -20.95 | -4.15 | 29.11 | -2.44 | -6.36 | 21.42 | -11.47 | 8.92 | 3.9 |
| PAT Growth(%) | 16.14 | 4.14 | -57.47 | -33.29 | 66.79 | -15.28 | 12.23 | 98.72 | -24.62 | 23.07 | 15.51 |
| EPS Growth(%) | 13.84 | 5.93 | -57.12 | -2.35 | 28.72 | -15.28 | 37.48 | 69.64 | -25.99 | 19.86 | 15.51 |
| Debt/Equity(x) | 1.05 | 0.93 | 0.97 | 0.78 | 0.93 | 0.91 | 0.77 | 0.64 | 0.47 | 0.39 | 0.27 |
| Current Ratio(x) | 1.55 | 1.64 | 1.58 | 1.65 | 1.53 | 1.47 | 1.42 | 1.45 | 1.53 | 1.61 | 1.68 |
| Quick Ratio(x) | 0.92 | 0.95 | 0.92 | 0.99 | 1.01 | 0.97 | 0.89 | 0.91 | 0.94 | 1 | 1.08 |
| Interest Cover(x) | 2 | 1.93 | 1.49 | 1.51 | 1.58 | 1.54 | 1.63 | 1.95 | 1.83 | 2.08 | 2.27 |
| Total Debt/Mcap(x) | 2.4 | 1.21 | 1.42 | 0.68 | 0.75 | 1.52 | 2.89 | 1.34 | 0.6 | 0.5 | 0.22 |
| # | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 52.66 | 52.66 | 52.66 | 52.66 | 52.66 | 52.66 | 52.66 | 52.66 | 52.66 | 52.66 |
| FII | 0.56 | 1.94 | 1.78 | 2.1 | 2.38 | 3.29 | 3.08 | 2.53 | 3.38 | 2.98 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 46.78 | 45.4 | 45.56 | 45.24 | 44.97 | 44.05 | 44.26 | 44.81 | 43.96 | 44.36 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 |
| FII | 0.01 | 0.03 | 0.02 | 0.03 | 0.03 | 0.04 | 0.04 | 0.03 | 0.04 | 0.04 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.61 | 0.59 | 0.59 | 0.59 | 0.58 | 0.57 | 0.58 | 0.58 | 0.57 | 0.58 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
You May Also Know About
